Status:

UNKNOWN

Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid

Lead Sponsor:

Kwong Wah Hospital

Collaborating Sponsors:

Tung Wah Group of Hospitals

Conditions:

Idiopathic Inflammatory Myopathies

Osteoporosis, Osteopenia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Idiopathic inflammatory myopathies (IIM) patients are at high risk of development of reduced bone mineral density due to impairment of functional status due to the disease and a relatively high dose o...

Detailed Description

Background: With recent advances in diagnoses and classification of idiopathic inflammatory myopathies (IIM), an increasing number of newly diagnosed cases of IIM is expected. These patients are vuln...

Eligibility Criteria

Inclusion

  • All idiopathic inflammatory myopathies (IIMs) patients under follow-up in Kwong Wah Hospital are invited to participate in this study.
  • IIMs are diagnosed by rheumatologist according to Bohan and Peter Criteria. Eligible patients will have dual-energy X-ray absorptiometry (DEXA) scan performed at baseline.
  • Adult patients of at least 18 years of age and
  • Evidence of reduced BMD in osteopenia (defined by T-score of -0.1 to -2.5) or osteoporosis range (defined by T-score of \< -2.5) at baseline by dual-energy X-ray absorptiometry (DEXA) scan.

Exclusion

  • Pregnant patients
  • Patients with juvenile onset of disease (\<18 years of age)
  • Patients with pre-existing metabolic bone conditions
  • Patients who are already on osteoporotic treatment other than calcium and vitamin D (including bisphosphonates, denosumab, teriparatide, raloxifene or strontium)
  • Patients who are contraindicated to denosumab or zoledronic acid including severe renal impairment and hypersensitivity
  • Patients who are not able to give informed consent

Key Trial Info

Start Date :

August 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2021

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04034199

Start Date

August 15 2019

End Date

March 31 2021

Last Update

July 26 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kwong Wah Hospital

Hong Kong, Hong Kong, 00000